• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清和脑脊液中的神经丝轻链及针对它们的抗体在临床孤立综合征和多发性硬化中的研究。

Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis.

机构信息

Charles University in Prague, First Faculty of Medicine, Institute of Medical Biochemistry and Laboratory Diagnostics, Kateřinská 32, 121 08 Prague 2, Czech Republic.

出版信息

J Neuroimmunol. 2013 Sep 15;262(1-2):113-20. doi: 10.1016/j.jneuroim.2013.06.010. Epub 2013 Jul 17.

DOI:10.1016/j.jneuroim.2013.06.010
PMID:23870535
Abstract

A release of light neurofilament subunits (NFL) into cerebrospinal fluid (CSF) and serum in multiple sclerosis (MS) may induce an immune response. We examined CSF and serum NFL levels and IgG antibodies against NFL in 19 patients with a clinically isolated syndrome (CIS) early converted into MS, 20 CIS-non-converters, 23 MS patients and 32 controls. CSF NFL levels were significantly higher in all patient groups. The highest CSF or intrathecally (IT) synthesized anti-NFL antibodies and CSF/serum ratios of anti-NFL antibodies were observed in CIS-converters. CSF NFL and CSF or IT anti-NFL antibodies could be surrogate biomarkers of axonal injury in early MS.

摘要

神经丝轻链(NFL)在多发性硬化症(MS)患者的脑脊液(CSF)和血清中的释放可能会引发免疫反应。我们检测了 19 例临床孤立综合征(CIS)患者(早期转化为 MS)、20 例 CIS 非转化患者、23 例 MS 患者和 32 例对照者的 CSF 和血清中 NFL 水平和针对 NFL 的 IgG 抗体。所有患者组的 CSF NFL 水平均显著升高。CIS 转化者的 CSF 或鞘内(IT)合成的抗-NFL 抗体以及 CSF/血清抗-NFL 抗体比值最高。CSF NFL 和 CSF 或 IT 抗-NFL 抗体可能是早期 MS 轴突损伤的替代生物标志物。

相似文献

1
Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis.血清和脑脊液中的神经丝轻链及针对它们的抗体在临床孤立综合征和多发性硬化中的研究。
J Neuroimmunol. 2013 Sep 15;262(1-2):113-20. doi: 10.1016/j.jneuroim.2013.06.010. Epub 2013 Jul 17.
2
Antibodies against light neurofilaments in multiple sclerosis patients.针对多发性硬化症患者轻链神经丝的抗体。
Acta Neurol Scand. 2007 Aug;116(2):100-7. doi: 10.1111/j.1600-0404.2006.00794.x.
3
A comparative study of CSF neurofilament light and heavy chain protein in MS.MS 患者脑脊液神经丝轻链和重链蛋白的比较研究。
Mult Scler. 2013 Oct;19(12):1597-603. doi: 10.1177/1352458513482374. Epub 2013 Mar 25.
4
Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis.多发性硬化症早期的血清和脑脊液重神经丝及其抗体。
J Neuroimmunol. 2013 Jun 15;259(1-2):81-7. doi: 10.1016/j.jneuroim.2013.03.009. Epub 2013 Apr 28.
5
Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease.中枢神经系统炎性脱髓鞘疾病患者脑脊液神经丝轻链增加。
Mult Scler Relat Disord. 2019 May;30:123-128. doi: 10.1016/j.msard.2019.02.009. Epub 2019 Feb 8.
6
Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.神经丝轻链和重链亚基在多发性硬化症中的治疗性生物标志物比较。
Acta Neurol Scand. 2013 Dec;128(6):e33-6. doi: 10.1111/ane.12151. Epub 2013 Jun 13.
7
[Neurofilament protein light in multiple sclerosis].[多发性硬化症中的神经丝轻链蛋白]
Zhonghua Yi Xue Za Zhi. 2007 Oct 23;87(39):2745-9.
8
Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者脑脊液和血清中神经丝抗体。
Eur J Neurol. 2010 Apr;17(4):562-6. doi: 10.1111/j.1468-1331.2009.02853.x. Epub 2009 Nov 24.
9
Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of multiple sclerosis.脑脊液神经丝追踪多发性硬化首次发作时注意力的功能磁共振成像相关因素。
Mult Scler. 2015 Apr;21(4):396-401. doi: 10.1177/1352458514546789. Epub 2014 Aug 28.
10
Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.脑脊液中N-乙酰天门冬氨酸与神经丝蛋白在多发性硬化症中的联合研究
Neurology. 2009 Apr 14;72(15):1322-9. doi: 10.1212/WNL.0b013e3181a0fe3f.

引用本文的文献

1
Autoimmune astrocytopathy double negative for AQP4-IgG and GFAP-IgG: Retrospective research of clinical practice, biomarkers, and pathology.水通道蛋白4-免疫球蛋白(AQP4-IgG)和胶质纤维酸性蛋白-免疫球蛋白(GFAP-IgG)双阴性的自身免疫性星形细胞病:临床实践、生物标志物及病理学的回顾性研究
CNS Neurosci Ther. 2024 Sep;30(9):e70042. doi: 10.1111/cns.70042.
2
Cerebrospinal fluid neurofilament light chain in acute optic neuritis and its predictive ability of multiple sclerosis.急性视神经炎中的脑脊液神经丝轻链及其对多发性硬化症的预测能力。
J Neurol. 2024 Sep;271(9):6127-6135. doi: 10.1007/s00415-024-12587-8. Epub 2024 Jul 25.
3
Role of Specific Autoantibodies in Neurodegenerative Diseases: Pathogenic Antibodies or Promising Biomarkers for Diagnosis.
特定自身抗体在神经退行性疾病中的作用:致病抗体还是有前景的诊断生物标志物?
Antibodies (Basel). 2023 Dec 8;12(4):81. doi: 10.3390/antib12040081.
4
Impaired intestinal permeability in patients with multiple sclerosis.多发性硬化症患者肠道通透性受损。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2025 Mar;169(1):37-43. doi: 10.5507/bp.2023.033. Epub 2023 Aug 11.
5
A Scoping Review on Body Fluid Biomarkers for Prognosis and Disease Activity in Patients with Multiple Sclerosis.多发性硬化症患者预后和疾病活动的体液生物标志物的范围综述
J Pers Med. 2022 Aug 31;12(9):1430. doi: 10.3390/jpm12091430.
6
Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis.多发性硬化症患者脑脊液中神经退行性变和轴突功能障碍生物标志物的比较分析
J Clin Med. 2022 Jul 15;11(14):4122. doi: 10.3390/jcm11144122.
7
Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases.针对神经原蛋白的自身抗体可作为神经退行性疾病的生物标志物。
Theranostics. 2022 Mar 28;12(7):3045-3056. doi: 10.7150/thno.72126. eCollection 2022.
8
Antibodies to neurofilament light as potential biomarkers in multiple sclerosis.神经丝轻链抗体作为多发性硬化症的潜在生物标志物
BMJ Neurol Open. 2021 Nov 11;3(2):e000192. doi: 10.1136/bmjno-2021-000192. eCollection 2021.
9
The Evolution of Neurofilament Light Chain in Multiple Sclerosis.多发性硬化症中神经丝轻链的演变
Front Neurosci. 2021 Apr 6;15:642384. doi: 10.3389/fnins.2021.642384. eCollection 2021.
10
Drug Treatment of Clinically Isolated Syndrome.临床孤立综合征的药物治疗。
CNS Drugs. 2019 Jul;33(7):659-676. doi: 10.1007/s40263-019-00647-x.